Ignite Creation Date:
2024-10-25 @ 7:59 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06635317
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-10-07
Brief Title:
Efficacy of Aspirin in Preventing Venous Thromboembolism
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Efficacy of Arpirin in Preventing Venous Thromboembolism in Total Knee and Hip Replacement
Status:
COMPLETED
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Efficacy of aspirin and enoxaparin in preventing venous tromboembolism was compared after total knee or hip arthroplasty
Detailed Description:
Background Venous thromboembolism VTE remains a significant risk following joint replacements despite advancements in prevention strategies Aspirin-based therapies have gained popularity due to their perceived safety ease of administration and supportive evidenceThis study aimed to compare the efficacy of aspirin and enoxaparin in preventing VTE after total knee or hip arthroplasty
Methods Sixty patients undergoing primary total knee or hip arthroplasty were randomized to receive either aspirin or enoxaparin The primary outcome was symptomatic VTE within 90 days Patients were followed up for Doppler ultrasound evaluations
Methods Sixty patients undergoing primary total knee or hip arthroplasty were randomized to receive either aspirin or enoxaparin The primary outcome was symptomatic VTE within 90 days Patients were followed up for Doppler ultrasound evaluations
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None